US 11078190
Polymorphs of selinexor
granted A61KA61K31/497A61P
Quick answer
US patent 11078190 (Polymorphs of selinexor) held by Karyopharm Therapeutics Inc. expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Karyopharm Therapeutics Inc.
- Grant date
- Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/497, A61P, A61P35/00